# BPC-157 and blood vessel growth in rats and cells | PepVault

Source: https://pepvault.app/research/bpc-157-hsieh-2017

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [BPC-157](https://pepvault.app/research#bpc-157)

Animal study · rats

# BPC-157 sped blood flow recovery in rats with hind limb ischemia

Checked against the paper November 2026 Animal study [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

This paper adds rat and lab evidence that BPC-157 can boost blood vessel growth and blood flow recovery, but it is not a result in humans.

- **Kind:** Animal study
- **Studied in:** Rats
- **Published:** 2017
- **Journal:** J Mol Med (Berl)

## What they tested

The team set out to test whether BPC-157 helps new blood vessels form, and through which pathway it might work.

## How the study was done

A preclinical study combining a chick chorioallantoic membrane test, a lab endothelial tube formation test, rats with hind limb ischemia (reduced blood flow to a hind leg), and lab-grown human vascular endothelial cells (cells that line blood vessels). Blood flow in the rats was tracked by laser Doppler scanning, and muscle tissue was checked under the microscope.

<!--promo-->

PepVault for iPhone

## Taking BPC-157? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

In rats with hind limb ischemia, BPC-157 made blood flow in the affected muscle recover faster, and the muscle held more vessels and more VEGFR2 (a receptor for a blood vessel growth factor). In the chick membrane test and in a lab endothelial tube formation test, a sign of new vessel growth, BPC-157 raised vessel density. In human vascular endothelial cells, it raised VEGFR2 at the mRNA and protein level but did not raise VEGF-A, and it drew VEGFR2 into the cell and switched on the VEGFR2-Akt-eNOS pathway over time. Dynasore, a drug that blocks endocytosis (the cell's uptake of material from its surface), stopped VEGFR2 from being drawn in, held back the pathway, and blocked the rise in tube formation.

## What it doesn’t show

All results come from chick membranes, rats and lab-grown cells, so none of them show what BPC-157 does in people. The rat work looked at one type of leg blood flow injury and did not test other conditions.

## The paper

Hsieh et al. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. J Mol Med (Berl). 2017.

- [PubMed (PMID 27847966)](https://pubmed.ncbi.nlm.nih.gov/27847966/)
- [The paper (DOI 10.1007/s00109-016-1488-y)](https://doi.org/10.1007/s00109-016-1488-y)

## The compound

- [BPC-157: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/bpc-157)
- [BPC-157 dose guide](https://pepvault.app/lab/dosage/bpc-157)

## With this study

### BPC-157

- [BPC-157: the full reference](https://pepvault.app/peptides/bpc-157)
- [BPC-157 dose guide](https://pepvault.app/lab/dosage/bpc-157)

### Mixing charts

- [5 mg vial](https://pepvault.app/tools/reconstitution-calculator/bpc-157-5mg)
- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/bpc-157-10mg)

### Studies

- [BPC-157: 10 of 12 women reported full interstitial cystitis relief](https://pepvault.app/research/bpc-157-lee-2024)
- [BPC-157: 14 of 16 reported knee pain relief in a chart review](https://pepvault.app/research/bpc-157-lee-2021)
- [BPC-157: non-significant tendon gains in rats; TB-500 did better](https://pepvault.app/research/bpc-157-bicer-2026)
- [All 14 studies](https://pepvault.app/research#bpc-157)

### Compared with

- [Retatrutide vs BPC-157](https://pepvault.app/peptides/compare/retatrutide-vs-bpc-157)
- [Semaglutide vs BPC-157](https://pepvault.app/peptides/compare/semaglutide-vs-bpc-157)
- [BPC-157 vs TB-500](https://pepvault.app/peptides/compare/bpc-157-vs-tb-500)
- [KPV vs BPC-157](https://pepvault.app/peptides/compare/kpv-vs-bpc-157)
- [GHK-Cu vs BPC-157](https://pepvault.app/peptides/compare/ghk-cu-vs-bpc-157)
- [BPC-157 vs Thymosin Beta-4](https://pepvault.app/peptides/compare/bpc-157-vs-thymosin-beta-4)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

## More studies on BPC-157

- [BPC-157: 10 of 12 women reported full interstitial cystitis relief](https://pepvault.app/research/bpc-157-lee-2024) Clinical trial · people · 2024
- [BPC-157: 14 of 16 reported knee pain relief in a chart review](https://pepvault.app/research/bpc-157-lee-2021) Observational study · people · 2021
- [BPC-157: non-significant tendon gains in rats; TB-500 did better](https://pepvault.app/research/bpc-157-bicer-2026) Animal study · rats · 2026
- [BPC-157 reduced leg muscle damage after ischemia-reperfusion in rats](https://pepvault.app/research/bpc-157-y-ld-r-m-2026) Animal study · rats · 2026
- [BPC-157 closed duodenocolic fistulas in rats](https://pepvault.app/research/bpc-157-vukusic-2024) Animal study · rats · 2024
- [BPC-157 limited isoprenaline-induced heart attack damage in rats](https://pepvault.app/research/bpc-157-barisic-2022) Animal study · rats · 2022
- [Every study on BPC-157](https://pepvault.app/research#bpc-157)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking BPC-157? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking BPC-157? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### BPC-157

- [BPC-157: the full reference](https://pepvault.app/peptides/bpc-157)
- [BPC-157 dose guide](https://pepvault.app/lab/dosage/bpc-157)

### Mixing charts

- [5 mg vial](https://pepvault.app/tools/reconstitution-calculator/bpc-157-5mg)
- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/bpc-157-10mg)

### Studies

- [BPC-157: 10 of 12 women reported full interstitial cystitis relief](https://pepvault.app/research/bpc-157-lee-2024)
- [BPC-157: 14 of 16 reported knee pain relief in a chart review](https://pepvault.app/research/bpc-157-lee-2021)
- [BPC-157: non-significant tendon gains in rats; TB-500 did better](https://pepvault.app/research/bpc-157-bicer-2026)
- [All 14 studies](https://pepvault.app/research#bpc-157)

### Compared with

- [Retatrutide vs BPC-157](https://pepvault.app/peptides/compare/retatrutide-vs-bpc-157)
- [Semaglutide vs BPC-157](https://pepvault.app/peptides/compare/semaglutide-vs-bpc-157)
- [BPC-157 vs TB-500](https://pepvault.app/peptides/compare/bpc-157-vs-tb-500)
- [KPV vs BPC-157](https://pepvault.app/peptides/compare/kpv-vs-bpc-157)
- [GHK-Cu vs BPC-157](https://pepvault.app/peptides/compare/ghk-cu-vs-bpc-157)
- [BPC-157 vs Thymosin Beta-4](https://pepvault.app/peptides/compare/bpc-157-vs-thymosin-beta-4)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

<!--promo-->

PepVault for iPhone

## Taking BPC-157? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on BPC-157](https://pepvault.app/research#bpc-157)

## The library

- [BPC-157](https://pepvault.app/peptides/bpc-157)
- [BPC-157 dose guide](https://pepvault.app/lab/dosage/bpc-157)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
